HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » Forums & Groups » Main » General Discussion (Forum) » Studying Marijuana and It... » Reply #1

Response to n2doc (Original post)

Tue Jan 1, 2013, 10:07 PM

1. Will Israel patent the outcome of their research like the US has done?



Cannabinoid Patent Exclusivity Only Applies To One Condition

​Exclusive Interview: Dean Petkanas, CEO, KannaLife

(The Company Just Awarded An Exclusive Cannabinoid License By The Federal Government)

The exclusive rights to apply the cannabinoids found in marijuana as therapeutic agents awarded by the U.S. federal government to the firm KannaLife only apply to one specific medical condition, KannaLife's CEO told Toke of the Town Monday night.

Dean Petkanas, chief executive officer at KannaLife Sciences, told us that the exclusivity applies only for the development and sale of cannabinoid based therapeutics as antioxidants and neuroprotectants for use in the treatment of hepatic encephalopathy.


When it becomes common knowledge that the US Feds patented the use of the main ingredient in pot how long will they still be able to arrest growers?

Probably a long time because (seemingly) [strike]most[/strike] many people can't think anymore...

Reply to this post

Back to OP Alert abuse Link to post in-thread

Always highlight: 10 newest replies | Replies posted after I mark a forum
Replies to this discussion thread
Arrow 1 replies Author Time Post
n2doc Jan 2013 OP
LineNew Reply Will Israel patent the outcome of their research like the US has done?
green for victory Jan 2013 #1
Please login to view edit histories.